UY26208A1 - Antagonistas de los receptores de la il-8. - Google Patents

Antagonistas de los receptores de la il-8.

Info

Publication number
UY26208A1
UY26208A1 UY26208A UY26208A UY26208A1 UY 26208 A1 UY26208 A1 UY 26208A1 UY 26208 A UY26208 A UY 26208A UY 26208 A UY26208 A UY 26208A UY 26208 A1 UY26208 A1 UY 26208A1
Authority
UY
Uruguay
Prior art keywords
antagonists
receivers
chemokine
interleukin
compositions
Prior art date
Application number
UY26208A
Other languages
English (en)
Inventor
Deborah Bryan John Glea Benson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of UY26208A1 publication Critical patent/UY26208A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Esta invención se refiere a nuevos compuestos de la fórmula (I), y a composiciones de los mismos, útiles en el tratamiento de enfermedades mediadas por la quimioquina, interleuquina-8 (IL-8).
UY26208A 1999-06-16 2000-06-14 Antagonistas de los receptores de la il-8. UY26208A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14002599P 1999-06-16 1999-06-16

Publications (1)

Publication Number Publication Date
UY26208A1 true UY26208A1 (es) 2000-12-29

Family

ID=22489384

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26208A UY26208A1 (es) 1999-06-16 2000-06-14 Antagonistas de los receptores de la il-8.

Country Status (6)

Country Link
AU (1) AU5622400A (es)
CO (1) CO5190720A1 (es)
EC (1) ECSP003529A (es)
PE (1) PE20010320A1 (es)
UY (1) UY26208A1 (es)
WO (1) WO2000076508A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007022964A2 (de) 2005-08-24 2007-03-01 Abbott Gmbh & Co. Kg Hetaryl substituierte guanidinverbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684032A (en) * 1994-12-13 1997-11-04 Smithkline Beecham Corporation Compounds
US5780483A (en) * 1995-02-17 1998-07-14 Smithkline Beecham Corporation IL-8 receptor antagonists
JP2000507556A (ja) * 1996-03-28 2000-06-20 スミスクライン・ビーチャム・コーポレイション ケモカインのカルボン酸インドール阻害剤

Also Published As

Publication number Publication date
ECSP003529A (es) 2002-01-25
AU5622400A (en) 2001-01-02
CO5190720A1 (es) 2002-08-29
WO2000076508A1 (en) 2000-12-21
PE20010320A1 (es) 2001-05-18

Similar Documents

Publication Publication Date Title
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
EA200401309A1 (ru) Тризамещённые гетероарилы и способы их получения и применения
BG66084B1 (bg) Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
ECSP055851A (es) Derivados de indolil pirazinona utiles para el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis
EA200501333A1 (ru) 5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ
EA200300528A1 (ru) 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6
BR0313109A (pt) Ciclobuteno-1,2-dionas 3,4-dissubstituìdas como ligandos de receptor de quimiocina de cxc
BR0110968A (pt) Antagonistas dos receptores de il-8
EA200301142A1 (ru) Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6
EA200300527A1 (ru) Новые способы лечения синдрома "усталых ног"
EA200300829A1 (ru) Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6
CY1106514T1 (el) Ανταγωνιστες υποδοχεων il-8
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
PT1129096E (pt) Antagonistas de receptor de crf e metodos de tratamento relacionados com os mesmos
PA8579601A1 (es) Compuestos antiinflamatorios de di y trifloruro-triazolo-piridinas
CY1112135T1 (el) Ανταγωνιστες υποδοχεα il-8
SE9901077D0 (sv) Novel use
EA200300629A1 (ru) Конденсированные производные пурина как антагонисты рецепторов аденозина a
EA200301143A1 (ru) Производные гетероциклилалкокси-, алкилтио- и -алкиламинобензазола в качестве лигандов 5-гидрокситриптамина-6
BR0108867A (pt) Antagonistas de receptor il-8
SE9801494D0 (sv) Novel use
AR024350A1 (es) Antagonistas de los receptores de il-8
ECSP044971A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson
BR0307156A (pt) Derivado de pirimidina bicìclica fundida, composto, antagonistas de receptores e agentes profiláticos e terapêuticos
BRPI0416678A (pt) pirazolpirimidinas

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20100520